FMP
Apr 30, 2024 11:50 AM - Davit Kirakosyan
Eli Lilly & Co (NYSE:LLY) experienced a 6% increase in its share price in pre-market today, following the announcement of its first-quarter financial results for 2024, which exceeded earnings expectations and showcased a significant improvement in gross margin. The pharmaceutical company reported an earnings per share (EPS) of $2.58, surpassing the forecast of $2.48. Despite this, the company's revenue of $8.77 billion did not meet the expected $8.94 billion. The gross margin for the quarter was notably strong at 80.9%, an increase from 76.6% the previous year and above the anticipated 79.9%.
Looking ahead, Eli Lilly raised its EPS forecast for 2024 to a range of $13.50 to $14.00, significantly higher than the previous estimate of $12.50. Additionally, the company revised its revenue expectations upward to between $42.4 billion and $43.6 billion for the year, which is an increase of approximately $2 billion from its earlier projections. This optimistic adjustment is largely due to robust sales from its drugs Mounjaro and Zepbound and increased production capabilities anticipated for the remainder of the year.
Sep 11, 2023 1:38 PM - Rajnish Katharotiya
Price to Earnings is one of the key metrics use to value companies using multiples. The P/E ratio and other multiples are relative valuation metrics and they cannot be looked at in isolation. One of the problems with the P/E metric is the fact that if we are in the peak of a business cycle, earni...
Sep 11, 2023 1:49 PM - Rajnish Katharotiya
Price-to-Earnings ratio is a relative valuation tool. It is used by investors to find great companies at low prices. In this post, we will build a Python script to calculate Price Earnings Ratio for comparable companies. Photo by Skitterphoto on Pexels Price Earnings Ratio and Comparable Compa...
Nov 25, 2023 6:39 AM - Parth Sanghvi
Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...